Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, Christos PJ, Schifano E, Booth J, van Putten W, Skrabanek L, Campagne F, Mazumdar M, Greally JM, Valk PJ, Löwenberg B, Delwel R, Melnick A.

Cancer Cell. 2010 Jan 19;17(1):13-27. doi: 10.1016/j.ccr.2009.11.020. Epub 2010 Jan 7.

2.

DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.

Claus R, Plass C, Armstrong SA, Bullinger L.

Future Oncol. 2010 Sep;6(9):1415-31. doi: 10.2217/fon.10.110. Review.

PMID:
20919827
3.

New prognostic markers in acute myeloid leukemia: perspective from the clinic.

Foran JM.

Hematology Am Soc Hematol Educ Program. 2010;2010:47-55. doi: 10.1182/asheducation-2010.1.47. Review.

PMID:
21239770
4.

Epigenetics in AML.

Melnick AM.

Best Pract Res Clin Haematol. 2010 Dec;23(4):463-8. doi: 10.1016/j.beha.2010.09.017. Epub 2010 Nov 1. Review.

PMID:
21130408
5.

Origins of aberrant DNA methylation in acute myeloid leukemia.

Schoofs T, Berdel WE, Müller-Tidow C.

Leukemia. 2014 Jan;28(1):1-14. doi: 10.1038/leu.2013.242. Epub 2013 Aug 20. Review.

PMID:
23958917
6.

HELP for AML: methylation profiling opens new avenues.

Bullinger L, Armstrong SA.

Cancer Cell. 2010 Jan 19;17(1):1-3. doi: 10.1016/j.ccr.2009.12.033. Review.

7.

Stratification of acute myeloid leukemia based on gene expression profiles.

Mano H.

Int J Hematol. 2004 Dec;80(5):389-94. Review.

PMID:
15646648
8.

Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.

Baldus CD, Bullinger L.

Semin Oncol. 2008 Aug;35(4):356-64. doi: 10.1053/j.seminoncol.2008.04.006. Review.

PMID:
18692686
9.

Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

Falini B, Martelli MP, Bolli N, Sportoletti P, Liso A, Tiacci E, Haferlach T.

Blood. 2011 Jan 27;117(4):1109-20. doi: 10.1182/blood-2010-08-299990. Epub 2010 Oct 28. Review.

10.

DNA methylation as a pathogenic event and as a therapeutic target in AML.

Schoofs T, Müller-Tidow C.

Cancer Treat Rev. 2011;37 Suppl 1:S13-8. doi: 10.1016/j.ctrv.2011.04.013. Epub 2011 May 25. Review.

PMID:
21612874
11.

Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management.

Ofran Y, Rowe JM.

Br J Haematol. 2013 Feb;160(3):303-20. doi: 10.1111/bjh.12135. Epub 2012 Dec 13. Review.

PMID:
23240632
12.

Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.

Wouters BJ, Delwel R.

Blood. 2016 Jan 7;127(1):42-52. doi: 10.1182/blood-2015-07-604512. Epub 2015 Dec 10. Review.

PMID:
26660432
13.

Epigenetic targeting and personalized approaches for AML.

Roboz GJ.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):44-51. doi: 10.1182/asheducation-2014.1.44. Epub 2014 Nov 18. Review.

PMID:
25696833
14.

Gene mutations of acute myeloid leukemia in the genome era.

Naoe T, Kiyoi H.

Int J Hematol. 2013 Feb;97(2):165-74. doi: 10.1007/s12185-013-1257-4. Epub 2013 Jan 29. Review.

PMID:
23359299
15.

An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.

Godley LA, Cunningham J, Dolan ME, Huang RS, Gurbuxani S, McNerney ME, Larson RA, Leong H, Lussier Y, Onel K, Odenike O, Stock W, White KP, Le Beau MM.

Semin Oncol. 2011 Apr;38(2):215-24. doi: 10.1053/j.seminoncol.2011.01.003. Review.

PMID:
21421111
16.

Epigenetic profiling joins personalized cancer medicine.

Heyn H, Méndez-González J, Esteller M.

Expert Rev Mol Diagn. 2013 Jun;13(5):473-9. doi: 10.1586/erm.13.36. Review.

PMID:
23782254
Items per page

Supplemental Content

Write to the Help Desk